Talley and a the vice president from Cephalon will inform about the topic above. Will we have the first numbers from sales here? :-)
"On Wednesday, September 30th, key stakeholders in the debate over access will convene in Washington, DC to share their perspectives in an interactive forum. The goal of this first-of-its-kind event is to provide a better understanding of the many viewpoints surrounding access to investigational drugs."